<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1814-6023-2023-20-1-17-27</article-id><article-id custom-type="elpub" pub-id-type="custom">vestim-888</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>О значимости активности аргиназы печени и клеток Купфера в развитии вторичной атерогенной дислипидемии и формировании тиреоидного статуса у крыс с экспериментальным перитонитом</article-title><trans-title-group xml:lang="en"><trans-title>On the significance of the activity of liver arginase and Kupffer cells in the development of secondary atherogenic dyslipidemia and the formation of thyroid status in rats with experimental peritonitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чепелева</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chepeleva</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чепелева Елена Николаева – ст. преподаватель</p><p>пр-т Дзержинского, 83, 220116, г. Минск</p><p> </p></bio><bio xml:lang="en"><p>Elena N. Chepeleva – Senior lecturer</p><p>83, Dzerzhinski Ave., 220116, Minsk</p></bio><email xlink:type="simple">drhelen1993@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Висмонт</surname><given-names>Ф. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vismont</surname><given-names>F. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Висмонт Франтишек Иванович – член-корреспондент, д-р мед. наук, профессор, заведующий кафедрой</p><p>пр-т Дзержинского, 83, 220116, г. Минск</p></bio><bio xml:lang="en"><p>Frantishek I. Vismont – Corresponding Member, D. Sc. (Med.), Professor, Head of the Department</p><p>83, Dzerzhinski Ave., 220116, Minsk</p></bio><email xlink:type="simple">patfiz@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>03</month><year>2023</year></pub-date><volume>20</volume><issue>1</issue><fpage>17</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чепелева Е.Н., Висмонт Ф.И., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Чепелева Е.Н., Висмонт Ф.И.</copyright-holder><copyright-holder xml:lang="en">Chepeleva E.N., Vismont F.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/888">https://vestimed.belnauka.by/jour/article/view/888</self-uri><abstract><p>Перитонит является одним из тяжелейших осложнений различных заболеваний и повреждений органов брюшной полости. Диагноз перитонита в общем смысле подразумевает любую форму и степень выраженности воспаления брюшины. В настоящее время проблема перитонита остается актуальной, несмотря на имеющиеся достижения научно-технического прогресса. Так, несмотря на успехи современной хирургии, достижения асептики и антисептики, достаточно широкие возможности антибактериальной, инфузионной и детоксикационной терапии, частота возникновения перитонита и летальность от него остаются на высоком уровне.  </p><p>Целью исследования являлось выяснение значимости активности аргиназы печени и клеток Купфера в развитии вторичной атерогенной дислипидемии и формировании тиреоидного статуса у крыс с экспериментальным перитонитом.  </p><p>Установлено, что в условиях экспериментального перитонита у крыс снижается активность аргиназы печени, повышается содержание NO3 – /NO2 – и снижается уровень йодсодержащих гормонов щитовидной железы в крови, развивается вторичная атерогенная дислипопротеинемия. В изменениях содержания общего холестерина в печени, общего холестерина, холестерина липопротеинов, уровня йодсодержащих гормонов в крови и температуры тела при перитоните участвуют аргиназа печени и клетки Купфера. Снижение активности клеток Купфера при перитоните сопровождается повышением уровня трийодтиронина в крови, менее выраженным снижением активности аргиназы печени и ослаблением развития характерных изменений содержания общего холестерина в печени, холестерина липопротеинов в крови и препятствует развитию вторичной дислипопротеинемии. Депрессия аргиназы печени в условиях перитонита усугубляет изменение содержания общего холестерина в липопротеинах крови и печени, трийодтиронина в крови и способствует развитию вторичной дислипопротеинемии. </p></abstract><trans-abstract xml:lang="en"><p>Peritonitis is one of the most severe complications of various diseases and injuries of the abdominal organs. The diagnosis of peritonitis in a general sense implies any form and severity of inflammation of the peritoneum. Currently, the problem of peritonitis remains actual, despite the achievements of scientific and technological progress. So, despite the successes of modern surgery, the achievements of asepsis and antiseptics, the rather wide possibilities of antibacterial, infusion and detoxification therapy, the incidence of peritonitis and mortality from it remain at a high level. </p><p>The aim of the study was to elucidate the significance of the activity of liver arginase and Kupffer cells in the development of secondary atherogenic dyslipidemia and the formation of thyroid status in rats with experimental peritonitis.  </p><p>It has been established that under conditions of experimental peritonitis in rats, the activity of liver arginase decreases, the content of NO3 – /NO2 – increases and the level of iodine-containing thyroid hormones in the blood decreases, secondary atherogenic dyslipoproteinemia develops. Liver arginase and Kupffer cells are involved in changes in the content of total cholesterol in the liver, total cholesterol, lipoprotein cholesterol, the level of iodine-containing hormones in the blood and body temperature in peritonitis. A decrease in the activity of Kupffer cells in peritonitis is accompanied by an increase in the level of triiodothyronine in the blood, a less pronounced decrease in the activity of liver arginase and a weakening of the development of characteristic changes in the content of total cholesterol in the liver, lipoprotein cholesterol in the blood and prevents the development of secondary dyslipoproteinemia. Depression of liver arginase in conditions of peritonitis aggravates changes in the content of total cholesterol in blood and liver lipoproteins, triiodothyronine in the blood and contributes to the development of secondary dyslipoproteinemia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>экспериментальный перитонит</kwd><kwd>клетки Купфера</kwd><kwd>аргиназа печени</kwd><kwd>холестерин липопротеинов</kwd><kwd>йодсодержащие гормоны</kwd><kwd>печень</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental peritonitis</kwd><kwd>Kupffer cells</kwd><kwd>liver arginase</kwd><kwd>cholesterol lipoproteins</kwd><kwd>iodine-containing hormones</kwd><kwd>liver</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гостищев, В. К. Перитонит / В. К. Гостищев. – М. : Медицина, 1985. – 473 с.</mixed-citation><mixed-citation xml:lang="en">Gostishchev V. K. Peritonitis. Moscow, Meditsina Publ., 1985. 473 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hotchkiss, R. S. The pathophysiology and treatment of sepsis / R. S. Hotchkiss, I. E. Karl // N. Engl. J. Med. – 2003. – Vol. 348, N 2. – P. 138–150. https://doi.org/10.1056/NEJMra021333</mixed-citation><mixed-citation xml:lang="en">Hotchkiss R. S., Karl I. E. The pathophysiology and treatment of sepsis. New England Journal of Medicine, 2003, vol. 348, no. 2, pp. 138–150. https://doi.org/10.1056/NEJMra021333</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Перитонит как одна из основных причин летальных исходов / Н. Д. Томнюк [и др.] // Соврем. наукоемкие технологии. – 2010. – № 10. – С. 81–84. 4. Перитонит : учеб.-практ. пособие / Э. Г. Абдуллаев [и др.] ; Иван. гос. мед. акад ; Владим. гос. ун-т им. А. Г. и Н. Г. Столетовых. – Владимир : Изд-во ВлГУ, 2014. – 144 с.</mixed-citation><mixed-citation xml:lang="en">Tomnyuk N. D., Danilina E. P., Chernykh A. N., Parno A. A., Shurka K. S. Peritonitis as one of the main causes of lethal outcomes. Sovremennye naukoemkie tekhnologii [Modern high technologies], 2010, no. 10, pp. 81–84 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гоженко, А. И. Особенности течения экспериментального перитонита у крыс при промывании брюшной полости / А. И. Гоженко, А. А. Васильев, Б. А. Насибуллин // Свiт медицини та бiологii. – 2014. – № 2 (44). – С. 111–114.</mixed-citation><mixed-citation xml:lang="en">Abdullaev E. G., Babyshin V. V., Novikov Yu. A., Gusev A. V., Malakhov N. B. Peritonitis. Vladimir, Vladimir State University Publishing House, 2014. 144 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Мишнев, О. Д. Патология печени при сепсисе / О. Д. Мишнев, У. Н. Туманова, А. И. Щеголев // Междунар. журн. приклад. и фунд. исслед. – 2017. – № 8-2. – С. 267–271.</mixed-citation><mixed-citation xml:lang="en">Gozhenko A. I., Vasil’ev A. A., Nasibullin В. А. Peculiarities of experimental peritonitis in rats by irrigation the abdominal cavity with xenon saturated solution. Svit meditsini ta biologii [The world of medicine and biology], 2014, no. 2 (44), pp. 111–114 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Короткевич, Т. В. Вторичная дислипопротеинемия и дисфункция печени в условиях экспериментальной эндотоксинемии / Т. В. Короткевич, Ф. И. Висмонт // Здравоохранение. – 2006. – № 6. – С. 21–23.</mixed-citation><mixed-citation xml:lang="en">Mishnev O. D., Tumanova U. N., Shchegolev A. I. Pathology of the liver in sepsis. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii [International journal of applied and basic research], 2017, no. 8-2, pp. 267–271 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Викторов, А. В. Связывание липополисахарида и комплексов липополисахарида с сывороточными липопротеинами низкой плотности с макрофагами печени / А. В. Викторов, В. А. Юркив // Биомед. химия. – 2006. – Т. 52, № 1. – С. 36–43.</mixed-citation><mixed-citation xml:lang="en">Korotkevich T. V., Vismont F. I. Secondary dyslipoproteinemia and liver dysfunction in experimental endotoxinemia. Zdravookhranenie [Health care], 2006, no. 6, pp. 21–23 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Чепелева, Е. Н. Особенности метаболизма холестерина липопротеинов крови у крыс при экспериментальном перитоните / Е. Н. Чепелева, Ф. И. Висмонт // БГМУ в авангарде медицинской науки и практики : рецензир. ежегод. сб. науч. тр. / Белорус. гос. мед. ун-т ; редкол. : С. П. Рубникович, В. Я. Хрыщанович. – Минск, 2020. – Вып. 10. – С. 390–394.</mixed-citation><mixed-citation xml:lang="en">Viktorov A. V., Yurkiv V. A. Binding of lipopolysaccharide and complexes of lipopolysaccharide with serum low density lipoproteins to liver macrophages. Biomeditsinskaya khimiya [Biomedical chemistry], 2006, vol. 52, no. 1, pp. 36–43 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lipid metabolism in inflammation-related diseases / C. Zhang [et al.] // Analyst. – 2018. – Vol. 143, N 19. – P. 4526– 4536. https://doi.org/10.1039/c8an01046c</mixed-citation><mixed-citation xml:lang="en">Chepeleva E. N., Vismont F. I. Peculiarities of blood lipoprotein cholesterol metabolism in rats with experimental peritonitis. BGMU v avangarde meditsinskoi nauki i praktiki: retsenziruemyi ezhegodnyi sbornik nauchnykh trudov. Vypusk 10 [BSMU at the forefront of medical science and practice: a peer-reviewed annual collection of scientific papers. Iss. 10]. Minsk, 2020, pp. 390–394 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Human very low density lipoproteins and chylomicrons can protect against endotoxininduced death in mice / H. W. Harris [et al.] // J. Clin. Invest. – 1990. – Vol. 86, N 3. – P. 696–702. https://doi.org/10.1172/JCI114765</mixed-citation><mixed-citation xml:lang="en">Zhang C., Wang K., Yang L., Liu R., Chu Y., Qin X., Yang P., Yu H. Lipid metabolism in inflammation-related diseases. Analyst, 2018, vol. 143, no. 19, pp. 4526–4536. https://doi.org/10.1039/c8an01046c</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">HDL-cholesterol level and cortisol response to synacthen in critically ill patients / P. H. J. van der Voort [et al.] // Intensive Care Med. – 2003. – Vol. 29, N 12. – P. 2199–2203. https://doi.org/10.1007/s00134-003-2021-7</mixed-citation><mixed-citation xml:lang="en">Harris H. W., Grunfeld C., Feingold K. R., Rapp J. H. Human very low density lipoproteins and chylomicrons can protect against endotoxininduced death in mice. Journal of Clinical Investigation, 1990, vol. 86, no. 3, pp. 696–702. https:// doi.org/10.1172/JCI114765</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Висмонт, Ф. И. О роли клеток Купфера и гепатоцитов в механизмах реализации влияния трийодтиронина на процессы детоксикации и регуляции температуры тела / Ф. И. Висмонт, С. А. Артюшкевич // Белорус. мед. журн. – 2005. – Т. 13, № 3. – С. 45–47.</mixed-citation><mixed-citation xml:lang="en">van der Voort P. H. J., Gerritsen R. T., Bakker A. J., Boerma E. Ch., Kuiper M. A., de Heide L. HDL-cholesterol level and cortisol response to synacthen in critically ill patients. Intensive Care Medicine, 2003, vol. 29, no. 12, pp. 2199–2203. https://doi.org/10.1007/s00134-003-2021-7</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Висмонт, Ф. И. Эндотоксинемия, дисрегуляция и формирование предболезни / Ф. И. Висмонт // Вес. Нац. акад. наук Беларуси. Сер. мед. наук. – 2018. – Т. 15, № 1. – С. 7–16.</mixed-citation><mixed-citation xml:lang="en">Vismont F. I., Artyushkevich S. A. On the role of Kupffer cells and hepatocytes in the mechanisms of implementation of triiodothyronine influence on the processes of detoxification and regulation of body temperature. Belorusskii meditsinskii zhurnal [Belarusian medical journal], 2005, vol. 13, no. 3, pp. 45–47 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Маянский, Д. Н. Клетки Купфера и патология печени / Д. Н. Маянский // Патолог. физиология и эксперим. медицина. – 1985. – № 4. – С. 80–86.</mixed-citation><mixed-citation xml:lang="en">Vismont F. I. Endotoxinemia, dysregulation and the pre-illness formation. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seriya meditsinskikh navuk = Proceedings of the National Academy of Sciences of Belarus. Medical series, 2018, vol. 15, no. 1, pp. 7–16 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Blockade of Kupffer cells prevents the febrile and preoptic prostaglandin E2 responses to intravenous lipopolysaccharide in guinea pigs / E. Sehic [et al.] // Ann. NY Acad. Sci. – 1997. – Vol. 813, N 1. – P. 448–452. https://doi.org/ 10.1111/j.1749-6632.1997.tb51732.x</mixed-citation><mixed-citation xml:lang="en">Mayanskii D. N. Kupffer cells and liver pathology. Patologicheskaya fiziologiya i eksperimental’naya meditsina [Pathological physiology and experimental medicine], 1985, no. 4, pp. 80–86 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Volmar, B. Modulation of Kupfer cells activity by gadolinium chloride in endotoxemic rats / B. Volmar, D. Rettinger, G. A. Wanner // Shock. – 1996. – Vol. 6, N 6. – P. 434–441. https://doi.org/10.1097/00024382-199612000-00008</mixed-citation><mixed-citation xml:lang="en">Sehic E., Hunter W. S., Ungar A. L., Blatteis C. M. Blockade of Kupffer cells prevents the febrile and preoptic prostaglandin E2 responses to intravenous lipopolysaccharide in guinea pigs. Annals of the New York Academy of Sciences, 1997, vol. 813, no. 1, pp. 448–452. https://doi.org/10.1111/j.1749-6632.1997.tb51732.x</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective / G. S. Clemente [et al.] // Int. J. Mol. Sci. – 2020. – Vol. 21, N 15. – P. 5291. https://doi.org/10.3390/ijms21155291</mixed-citation><mixed-citation xml:lang="en">Volmar B., Rettinger D., Wanner G. A. Modulation of Kupfer cells activity by gadolinium chloride in endotoxemic rats. Shock, 1996, vol. 6, no. 6, pp. 434–441. https://doi.org/10.1097/00024382-199612000-00008</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils / C. J. Darcy [et al.] // Clin. Chem. Lab. Med. – 2014. – Vol. 52, N 4. – P. 573–581. https://doi.org/10.1515/cclm-2013-0698</mixed-citation><mixed-citation xml:lang="en">Clemente G. S., van Waarde A., Antunes I. F., Dömling A., Elsinga P. H. Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective. International Journal of Molecular Sciences, 2020, vol. 21, no. 15, p. 5291. https://doi.org/10.3390/ijms21155291</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis / C. E. Douma [et al.] // Lab. Clin. Med. – 1998. – Vol. 132, N 4. – P. 329–340. https://doi.org/10.1016/S0022-2143(98)90047-6</mixed-citation><mixed-citation xml:lang="en">Darcy C. J., Woodberry T., Davis J. S., Piera K. A., McNeil Y. R., Chen Y., Yeo T. W., Weinberg J. B., Anstey N. M. Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils. Clinical Chemistry and Laboratory Medicine, 2014, vol. 52, no. 4, pp. 573–581. https://doi.org/10.1515/cclm-2013-0698</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nitric oxide synthase isoforms play distinct roles during acute peritonitis / J. Ni [et al.] // Nephrol. Dial. Transplant. – 2010. – Vol. 25, N 1. – P. 86‒96. https://doi.org/10.1093/ndt/gfp415</mixed-citation><mixed-citation xml:lang="en">Douma C. E., de Waart D. R., Struijk D. G., Krediet R. T. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? Journal of Laboratory and Clinical Medicine, 1998, vol. 132, no. 4, pp. 329–340. https://doi.org/10.1016/S0022-2143(98)90047-6</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly, G. S. Peripheral Metabolism of Thyroid Hormones : a review / G. S. Kelly // Altern. Med. Rev. – 2000. – Vol. 5, N 4. – P. 306–333.</mixed-citation><mixed-citation xml:lang="en">Ni J., McLoughlin R. M., Brodovitch A., Moulin P., Brouckaert P., Casadei B., Feron O., Topley N., Balligand J.-L., Devuyst O. Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrology Dialysis Transplantation, 2010, vol. 25, no. 1, pp. 86–96. https://doi.org/10.1093/ndt/gfp415</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Функциональное состояние щитовидной железы и липидный профиль крови / С. В. Мустафина [и др.] // Атеросклероз. – 2010. – Т. 6, № 2. – С. 15–19.</mixed-citation><mixed-citation xml:lang="en">Kelly G. S. Peripheral metabolism of thyroid hormones: a review. Alternative Medicine Review: a Journal of Clinical Therapeutic, 2000, vol. 5, no. 4, pp. 306–333.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чепелева, Е. Н. Клетки Купфера в регуляции содержания холестерина в печени и липопротеинах крови, уровня йодсодержащих гормонов щитовидной железы в крови и температуры тела у крыс с экспериментальным перитонитом / Е. Н. Чепелева, Ф. И. Висмонт // Вес. Нац. акад. наук Беларуси. Сер. мед. наук. – 2021. – Т. 18, № 4. – С. 391–401.</mixed-citation><mixed-citation xml:lang="en">Mustafina S. V., Rymar O. D., Simonova G. I., Ragino Yu. I., Kuznetsov A. A., Shcherbakova L. V., Malyutina S. K. Functional state of thyroid gland and lipid blood profile. Ateroskleroz [Atherosclerosis], 2010, vol. 6, no. 2, pp. 15–19 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Моделирование экспериментального сепсиса путем выполнения лигирования и пункции слепой кишки (CLP-процедура) / Е. Ю. Шаповалова [и др.] // Ульянов. мед.-биол. журн. – 2020. – № 3. – С. 150–158.</mixed-citation><mixed-citation xml:lang="en">Chepeleva E. N., Vismont F. I. Kupffer cells in the regulation of the cholesterol content in the liver and the blood lipoproteins, the level of iodine-containing thyroid hormones in the blood and the body temperature in rats with experimental peritonitis. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seriya meditsinskikh navuk = Proceedings of the National Academy of Sciences of Belarus. Medical series, 2021, vol. 18, no. 4, pp. 391–401 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Immunodesign of experimental sepsis by cecal ligation and puncture / D. Rittirsch [et al.] // Nat. Protocols. – 2009. – Vol. 4, N 1. – P. 31–36. https://doi.org/10.1038/nprot.2008.214</mixed-citation><mixed-citation xml:lang="en">Shapovalova E. Yu., Demyashkin G. A., Malanichev M. Yu., Pogosyan D. A., Zorin I. A., Shchekin V. I. Simulation of experimental sepsis by cecal ligation and puncture (CLP). Ul’yanovskii mediko-biologicheskii zhurnal [Ulyanovsk medical and biological journal], 2020, no. 3, pp. 150–158 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Geyer, J. W. Rapid method for determination of arginase activity in tissue homogenates / J. W. Geyer, D. Dabich // Anal. Biochem. – 1971. – Vol. 39, N 2. – P. 412–417. https://doi.org/10.1016/0003-2697(71)90431-3</mixed-citation><mixed-citation xml:lang="en">Rittirsch D., Huber-Lang M. S., Flierl M. A., Ward P. A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols, 2009, vol. 4, no. 1, pp. 31–36. https://doi.org/10.1038/nprot.2008.214</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Burstein, M. Sur la clarification du sérum lipémique par l’héparine in vitro / M. Burstein, J. Samaille // C. R. Acad. Sci. (Paris). – 1955. – Vol. 241, N 9. – P. 664–665.</mixed-citation><mixed-citation xml:lang="en">Geyer J. W., Dabich D. Rapid method for determination of arginase activity in tissue homogenates. Analytical Biochemistry, 1971, vol. 39, no. 2, pp. 412–417. https://doi.org/10.1016/0003-2697(71)90431-3</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Крехова, М. А. Фракционное определение эфиров холестерина в крови и тканях с помощью хроматографии в тонком слое / М. А. Крехова, М. К. Чехранова // Вопр. мед. химии. – 1971. – Т. 17, № 1. – С. 93–98.</mixed-citation><mixed-citation xml:lang="en">Burstein M., Samaille J. Sur la clarification du sérum lipémique par l’héparine in vitro. Comptes rendus hebdomadaires des séances de l’Académie des sciences, 1955, vol. 241, no. 9, pp. 664–665.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Nitrite and nitrate determinations in plasma: a critical evaluation / H. Moshage [et al.] // Clin. Chem. – 1995. – Vol. 41, N 6. – P. 892–896. https://doi.org/10.1093/clinchem/41.6.892</mixed-citation><mixed-citation xml:lang="en">Krekhova M. A., Chekhranova M. K. Fractional determination of cholesterol esters in blood and tissues using thin layer chromatography. Voprosy meditsinskoi khimii [Medicinal chemistry issues], 1971, vol. 17, no. 1, pp. 93–98 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Методы клинических лабораторных исследований / В. С. Камышников [и др.] ; под ред. В. С. Камышникова. – 10-е изд. – М. : МЕДпресс-информ, 2020. – 736 с.</mixed-citation><mixed-citation xml:lang="en">Moshage H., Kok B., Huizenga J. R., Jansen P. L. Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry, 1995, vol. 41, no. 6, pp. 892–896. https://doi.org/10.1093/clinchem/41.6.892</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Duntas, L. H. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism / L. H. Duntas, E. Mantzou, D. A. Koutras // Thyroid. – 2002. – Vol. 12, N 11. – P. 1003–1007. https://doi.org/10.1089/105072502320908349</mixed-citation><mixed-citation xml:lang="en">Kamyshnikov V. S., Volotovskaya O. A., Khodyukova A. B., Dal’nova T. S., Vasiliu-Svetlitskaya S. G., Zubovskaya E. T., Alekhnovich L. I. Clinical laboratory research methods. 10th ed. Moscow, MEDpress-inform Publ., 2020. 736 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Duntas L. H., Mantzou E., Koutras D. A. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid, 2002, vol. 12, no. 11, pp. 1003–1007. https://doi.org/10.1089/105072502320908349</mixed-citation><mixed-citation xml:lang="en">Duntas L. H., Mantzou E., Koutras D. A. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid, 2002, vol. 12, no. 11, pp. 1003–1007. https://doi.org/10.1089/105072502320908349</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
